These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9324292)

  • 81. Leukocyte-associated Ig-like receptor-1 prevents granulocyte-monocyte colony stimulating factor-dependent proliferation and Akt1/PKB alpha activation in primary acute myeloid leukemia cells.
    Zocchi MR; Pellegatta F; Pierri I; Gobbi M; Poggi A
    Eur J Immunol; 2001 Dec; 31(12):3667-75. PubMed ID: 11745387
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases.
    Dunphy CH; Tang W
    Arch Pathol Lab Med; 2007 May; 131(5):748-54. PubMed ID: 17488160
    [TBL] [Abstract][Full Text] [Related]  

  • 83. The characterization of chemokine production and chemokine receptor expression reveals possible functional cross-talks in AML blasts with monocytic differentiation.
    Cignetti A; Vallario A; Roato I; Circosta P; Strola G; Scielzo C; Allione B; Garetto L; Caligaris-Cappio F; Ghia P
    Exp Hematol; 2003 Jun; 31(6):495-503. PubMed ID: 12829025
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells.
    Sutherland HJ; Blair A; Zapf RW
    Blood; 1996 Jun; 87(11):4754-61. PubMed ID: 8639846
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Lymphokine-activated killer (LAK) cells and cytokines synergize to kill clonal cells in acute myeloid leukemia (AML) in vitro.
    Braun S; Gerhartz HH; Schmetzer HM
    Haematologia (Budap); 2000; 30(4):271-88. PubMed ID: 11204027
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hepatocyte growth factor/scatter factor (HGF/SF) affects proliferation and migration of myeloid leukemic cells.
    Weimar IS; Voermans C; Bourhis JH; Miranda N; van den Berk PC; Nakamura T; de Gast GC; Gerritsen WR
    Leukemia; 1998 Aug; 12(8):1195-203. PubMed ID: 9697873
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The Expression Pattern of CD33 Antigen Can Differentiate Leukemic from Normal Progenitor Cells in Acute Myeloid Leukemia.
    Dutta S; Saxena R
    Indian J Hematol Blood Transfus; 2014 Jun; 30(2):130-4. PubMed ID: 24839368
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Fucose binding lectin for characterizing acute myeloid leukemia progenitor cells.
    Delwel R; Touw I; Bot F; Löwenberg B
    Blood; 1986 Jul; 68(1):41-5. PubMed ID: 3459560
    [TBL] [Abstract][Full Text] [Related]  

  • 89. PROFILE OF CD150 EXPRESSION IN BONE MARROW CELLS OF PATIENTS WITH ACUTE MYELOID LEUKEMIA.
    Shlapatska L; Gordiienko I; Polishchuk A; Gluzman D
    Exp Oncol; 2022 Nov; 44(3):198-207. PubMed ID: 36325710
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Analysis of acute myeloid leukemia cells by flow cytometry, introducing a new light-scattering classification.
    Harada N; Okamura S; Kubota A; Shimoda K; Ikematsu W; Kondo S; Harada M; Niho Y
    J Cancer Res Clin Oncol; 1994; 120(9):553-7. PubMed ID: 8045921
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Induction of tissue factor by interleukin-2 in acute myelogenous leukemia (AML) cells.
    Tanaka M; Kishi T
    Growth Factors; 1990; 4(1):1-8. PubMed ID: 2085439
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Expression of intercellular adhesion molecule-1 (CD54) on hematopoietic progenitors.
    Arkin S; Naprstek B; Guarini L; Ferrone S; Lipton JM
    Blood; 1991 Mar; 77(5):948-53. PubMed ID: 1671649
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Characterization of myelodysplastic syndromes hematopoietic stem and progenitor cells using mass cytometry.
    Bachas C; Duetz C; van Spronsen MF; Verhoeff J; Garcia Vallejo JJ; Jansen JH; Cloos J; Westers TM; van de Loosdrecht AA
    Cytometry B Clin Cytom; 2023 Mar; 104(2):128-140. PubMed ID: 35289472
    [TBL] [Abstract][Full Text] [Related]  

  • 94. GM-CSF-dependent pSTAT5 sensitivity is a feature with therapeutic potential in chronic myelomonocytic leukemia.
    Padron E; Painter JS; Kunigal S; Mailloux AW; McGraw K; McDaniel JM; Kim E; Bebbington C; Baer M; Yarranton G; Lancet J; Komrokji RS; Abdel-Wahab O; List AF; Epling-Burnette PK
    Blood; 2013 Jun; 121(25):5068-77. PubMed ID: 23632888
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The Role of Zinc in GM-CSF-Induced Signaling in Human Polymorphonuclear Leukocytes.
    van der Laan M; Büttgenbach A; Wolf J; Rink L; Wessels I
    Mol Nutr Food Res; 2022 Jul; 66(14):e2101106. PubMed ID: 35593658
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Linking GATA2 to myeloid dysplasia and complex cytogenetics in adult myelodysplastic neoplasm and acute myeloid leukemia.
    Robbins DJ; Pavletich TS; Patil AT; Pahopos D; Lasarev M; Polaki US; Gahvari ZJ; Bresnick EH; Matson DR
    Blood Adv; 2024 Jan; 8(1):80-92. PubMed ID: 38029365
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Surface phenotype of clonogenic cells in acute myeloid leukemia defined by monoclonal antibodies.
    Lange B; Ferrero D; Pessano S; Palumbo A; Faust J; Meo P; Rovera G
    Blood; 1984 Sep; 64(3):693-700. PubMed ID: 6590096
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Immunophenotypical profiling of myeloid neoplasms with erythroid predominance using mass cytometry (CyTOF).
    Maag AH; Swanton H; Kull M; Vegi NM; Feuring M
    Cytometry A; 2023 Jul; 103(7):551-562. PubMed ID: 36647792
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The monoclonal antibody 11G7 recognizes a novel differentiation antigen expressed on hemopoietic precursor cells.
    Bühring HJ; Saalmüller A; Müller C; van Agthoven AJ; Busch FW
    Hybridoma; 1991 Feb; 10(1):77-88. PubMed ID: 2032736
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Myeloblasts transition to megakaryoblastic immunophenotypes over time in some patients with myelodysplastic syndromes.
    Ogata K; Mochimaru Y; Sei K; Kawahara N; Ogata M; Yamamoto Y
    PLoS One; 2023; 18(9):e0291662. PubMed ID: 37729123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.